6515--NX EQ Defibrillators

Sources Sought Notice Sources Sought Notice Sources Sought Notice *= Required Field Sources Sought Notice 1.0 DESCRIPTION The Veterans Health Administration (VHA) Non-Expendable Equipment National Program has identified the Defibrillators product line as a candidate for a VA-wide (otherwise referred to as national ) multiple award Blanket Purchase Agreement (BPA). The Department of Veterans Affairs (DVA) Office of Procurement, Acquisition and Logistics (OPAL) Strategic Acquisition Center (SAC) on behalf of VHA is issuing this Request for Information (RFI) in accordance with the FAR 10.002(b)(2) to determine the availability and technical capabilities of qualified sources. The period of performance is for a 60-month ordering period from the date of award. The SAC in conjunction with VHA is seeking a qualified sources to manufacturer on an agency wide basis. VA intends to award a multiple award BPA with Firm-Fixed Price (FFP) orders IAW FAR 13.303, Blanket Purchase Agreement (BPA) to suppliers of this equipment. Vendors will be required to deliver Defibrillators to VA medical centers and facilities throughout the United States. The associated North American Industrial Classification System (NAICS) code for this procurement is 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing and the associated size standard is 1,250 employees. The FAR Provision found at 52.204-7(b)(1) requires that All interested Offerors must be registered in SAM prior to submitting an offer or quotation. You may access the SAM website at SAM.gov | Home. All offerors must be certified as with the appropriate NAICS code on the SAM website. All SDVOSB/VOSB offerors must be verified in the SBA database at https://veterans.certify.sba.gov/#search at the time of quote submission. This notice is for planning purpose only and does not constitute a commitment on the part of the Government to award a BPA, nor does the Government intend to pay for any information submitted as a result of this notice. This RFI is part of a continuous process for obtaining the latest information on the commercial status of the industry with respect to their current and near-term abilities. The information provided herein is subject to change and in no way binds the Government to solicit for, or award, a competitive contract. It is emphasized that this is a notice solely for planning and informational purposes 2.0 SCOPE Defibrillators, manual and automatic, deliver a high-voltage electrical impulse to the heart in order to restore normal rhythm and contractile function in patients who are experiencing ventricular fibrillation (VF), ventricular tachycardia (VT), or another shockable rhythm. An ECG monitor included with the unit is used to verify the presence of a shockable rhythm and the effectiveness of treatment. Defibrillators typically have three different types of operation: external defibrillation, internal defibrillation, and synchronized cardioversion. Defibrillators designed for use on adult patients should have energy settings of 20 to 200 J or 2 to 360 J. Those used for neonatal/pediatric, internal, or synchronized cardioversion applications should have additional low energy settings of 2 to 50 J. Defibrillators can be equipped with optional monitoring capabilities, such as pulse oximetry (SpO2), end-tidal carbon dioxide (EtCO2), and noninvasive blood pressure (NIBP). The following line item comprise the Defibrillators product line: CLIN # DESCRIPTION YEAR ONE YEAR TWO YEAR THREE YEAR FOUR YEAR FIVE 0001 Defibrillator Manual 433 294 319 14 273 0002 Defibrillator Automated External 774 406 124 294 75 Vendors who propose brands that meet all the minimum technical requirements (MTRs) below, should provide that information in the chart below in their response to this Sources Sought Notice. MANUFACTURERS PART NUMBERS DESCRIPTION YEAR ONE YEAR TWO YEAR THREE YEAR FOUR YEAR FIVE 433 294 319 14 273 774 406 124 294 75 The Department of Veterans Affairs (VA) is seeking vendors who can provide Defibrillators identified above which meet all the following minimum technical requirements (MTRs). Vendors are encouraged to provide any product solution or configuration so long as they meet the MTRs. Additionally, vendors responses can include any additional product that may be beneficial. These items must be clearly identified by brand name and part number. For each product the response must include descriptive literature demonstrating the product meets or exceeds the MTRs specified below. The Government's intent is to include all ancillary items to ensure the equipment can function as designed by the OEM and as clinically required. MTRS # MINIMUM TECHNICAL REQUIREMENTS (MTRS) METHOD OF EVALUATION APPLICABLE CLINS VENDOR S PROVIDE PAGE # WHERE EACH MTR IS MET IN YOUR TECHNICAL LITERATURE MTR 1 ECG Monitoring Literature Review 0001 MTR 2 Must have Automatic External Defibrillation Mode Literature Review 0001 MTR 3 Must Deliver Electric Current by Biphasic Waveform Literature Review 0001 MTR 4 Lead Fault Indicator Literature Review 0001 MTR 5 Real Time CPR Feedback Literature Review 0001 - 0002 MTR 6 FDA Approved Literature Review 0001 - 0002 MTR 7 Visual Prompts Literature Review 0002 MTR 8 Voice Prompting Literature Review 0002 MTR 9 CPR Technique Instruction Literature Review 0002 MTR 10 Self-Test Literature Review 0002 Responses to this Sources Sought Notice shall include the following: Full name and address of company DUNS number/ CAGE Code/ SAM UIE Business Size Manufacturer or Distributor If distributor provide full name, business size and address of manufacturer Country of Origin designation for all products Ability to provide uninterrupted supply of products on a national scale Technical Literature that clearly shows product(s) meet the identified minimum technical requirements (MTRs) and page numbers where each MTR is met Any additional product solution or configuration that would be beneficial to the clinical functionality of the product line identified Although not required, vendors responding to this Sources Sought may also submit a Capabilities Statement